Transfusion reaction: Difference between revisions
No edit summary |
|||
Line 44: | Line 44: | ||
The following table shows different types of transfusion reactions along with their treatment, | The following table shows different types of transfusion reactions along with their treatment, | ||
{| | {| | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Transfusion Reaction | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Transfusion Reaction | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Time of onset | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Time of onset | ||
Line 60: | Line 59: | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Anaphylactic Reaction | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Anaphylactic Reaction | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Rapid onset | * Rapid onset | ||
|<nowiki>-</nowiki> | | align="center" style="background:#F5F5F5;" |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | | align="center" style="background:#F5F5F5;" |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | | align="center" style="background:#F5F5F5;" |<nowiki>-</nowiki> | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* Hypotension | * Hypotension | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Wheezing | * Wheezing | ||
* stridor | * stridor | ||
* cyanosis | * cyanosis | ||
* soft tissue edema | * soft tissue edema | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* CBC | * CBC | ||
* spO2 monitoring | * spO2 monitoring | ||
* type and screen | * type and screen | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Stop the transfusion immediately | * Stop the transfusion immediately | ||
* S/C epinephrine | * S/C epinephrine | ||
* IV epinephrine(in case of severe hypotension) | * IV epinephrine(in case of severe hypotension) | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Avoid clerical errors | * Avoid clerical errors | ||
* proper storage record | * proper storage record | ||
* repeat type and screen before transfusion | * repeat type and screen before transfusion | ||
* proper blood storage conditions | * proper blood storage conditions | ||
|[[IgA deficiency]] | | align="center" style="background:#F5F5F5;" | [[IgA deficiency]] | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Bacterial Infection | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Bacterial Infection | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Rapid onset | * Rapid onset | ||
| ++ | | align="center" style="background:#F5F5F5;" | ++ | ||
| + | | align="center" style="background:#F5F5F5;" |+ | ||
| +/- | | align="center" style="background:#F5F5F5;" |+/- | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Hypotension is common | * Hypotension is common | ||
* occasionally hypertension | * occasionally hypertension | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* fever > 2 | * fever > 2 | ||
* tachycardia | * tachycardia | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* CBC | * CBC | ||
* Urine complete examination | * Urine complete examination | ||
Line 105: | Line 104: | ||
* transfusion set culture | * transfusion set culture | ||
* clotting profile | * clotting profile | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Stop the transfusion | * Stop the transfusion | ||
* Check identity on blood unit | * Check identity on blood unit | ||
Line 112: | Line 111: | ||
* broad spectrum antibiotics for bacterial infections | * broad spectrum antibiotics for bacterial infections | ||
* inform blood bank | * inform blood bank | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Extensive screening of blood | * Extensive screening of blood | ||
* decrease storage time | * decrease storage time | ||
* leukodepletion | * leukodepletion | ||
* bactericidal treatment | * bactericidal treatment | ||
| +/- | | align="center" style="background:#F5F5F5;" | +/- | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Acute Hemolytic Reaction | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Acute Hemolytic Reaction | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Rapid onet | * Rapid onet | ||
|<nowiki>+</nowiki> | | align="center" style="background:#F5F5F5;" |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | | align="center" style="background:#F5F5F5;" |<nowiki>+</nowiki> | ||
|<nowiki>+/-</nowiki> | | align="center" style="background:#F5F5F5;" |<nowiki>+/-</nowiki> | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Hypotension | * Hypotension | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Chest pain | * Chest pain | ||
* apprehension | * apprehension | ||
Line 134: | Line 133: | ||
* [[Renal failure]] | * [[Renal failure]] | ||
* oozing from venipuncture site ( DIC) | * oozing from venipuncture site ( DIC) | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* CBC | * CBC | ||
* Urine complete examination | * Urine complete examination | ||
Line 143: | Line 142: | ||
* [[Prothrombin time]] | * [[Prothrombin time]] | ||
* [[Coomb's test]]=+ve | * [[Coomb's test]]=+ve | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Stop the transfusion immediately | * Stop the transfusion immediately | ||
* look for clerical errors | * look for clerical errors | ||
Line 151: | Line 150: | ||
* to prevent renal failure-give low dose dopamine,normal saline,mannitol for diuresis | * to prevent renal failure-give low dose dopamine,normal saline,mannitol for diuresis | ||
* Treat DIC(if happens) | * Treat DIC(if happens) | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Avoid clerical errors | * Avoid clerical errors | ||
* proper storage record | * proper storage record | ||
* repeat type and screen before transfusion | * repeat type and screen before transfusion | ||
* proper blood storage conditions | * proper blood storage conditions | ||
|[[ABO incompatibility (patient information)|ABO incompatibility]] | | align="center" style="background:#F5F5F5;" |[[ABO incompatibility (patient information)|ABO incompatibility]] | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Febrile Non-hemolytic Transfusion Reaction | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Febrile Non-hemolytic Transfusion Reaction | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* 1/2 to 1 hour | * 1/2 to 1 hour | ||
| +, with chills | | align="center" style="background:#F5F5F5;" | +, with chills | ||
|<nowiki>+</nowiki> | | align="center" style="background:#F5F5F5;" |<nowiki>+</nowiki> | ||
|<nowiki>-</nowiki> | | align="center" style="background:#F5F5F5;" |<nowiki>-</nowiki> | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* No Effect | * No Effect | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* can occur in first few hours | * can occur in first few hours | ||
* fever rise of 1-2 | * fever rise of 1-2 | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* No labs usually required | * No labs usually required | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Slow or Stop the transfusion | * Slow or Stop the transfusion | ||
* Give Acetaminophen for fever | * Give Acetaminophen for fever | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Leukoreduction | * Leukoreduction | ||
|Cytokine in storage | |Cytokine in storage | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Transfusion-related acute lung injury (TRALI) | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Transfusion-related acute lung injury (TRALI) | ||
|within 6 hours | | align="center" style="background:#F5F5F5;" |within 6 hours | ||
| +/- | | align="center" style="background:#F5F5F5;" |+/- | ||
| +/- | | align="center" style="background:#F5F5F5;" |+/- | ||
| - | | align="center" style="background:#F5F5F5;" |- | ||
| | | align="left" style="background:#F5F5F5;" | | ||
* Hypotension | * Hypotension | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* cough | * cough | ||
* pink frothy sputum | * pink frothy sputum | ||
* [[Respiratory distress]] | * [[Respiratory distress]] | ||
* [[Pulmonary edema]] | * [[Pulmonary edema]] | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* ABGs | * ABGs | ||
* CBC | * CBC | ||
Line 196: | Line 195: | ||
* CXR-pulmonary infiltrates | * CXR-pulmonary infiltrates | ||
* HLA typing(remove donor from the list) | * HLA typing(remove donor from the list) | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* Stop the transfusion immediately | * Stop the transfusion immediately | ||
* O2 inhalation | * O2 inhalation | ||
Line 204: | Line 203: | ||
* inform the blood bank | * inform the blood bank | ||
* consult hematologist | * consult hematologist | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* donor whose blood cause TRALI must be put on non-donor list | * donor whose blood cause TRALI must be put on non-donor list | ||
| Donor anti-leukocyte antibodies | | align="center" style="background:#F5F5F5;" | Donor anti-leukocyte antibodies | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Transfusion-associated circulatory overload (TACO) | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Transfusion-associated circulatory overload (TACO) | ||
|usually over hours | | align="center" style="background:#F5F5F5;" |usually over hours | ||
| - | | align="center" style="background:#F5F5F5;" |- | ||
| - | | align="center" style="background:#F5F5F5;" |- | ||
| - | | align="center" style="background:#F5F5F5;" |- | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* Hypertension | * Hypertension | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* dyspnea | * dyspnea | ||
* orthopnea | * orthopnea | ||
Line 224: | Line 223: | ||
* increase JVP | * increase JVP | ||
* increase CVP | * increase CVP | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* spO2 monitoring | * spO2 monitoring | ||
* CXR | * CXR | ||
* serum BNP | * serum BNP | ||
* ABGs | * ABGs | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* Stop transfusion | * Stop transfusion | ||
* Supportive therapy | * Supportive therapy | ||
Line 237: | Line 236: | ||
* exchange transfusion(if transfusion is unavoidable) | * exchange transfusion(if transfusion is unavoidable) | ||
* controlled phelbotomy | * controlled phelbotomy | ||
| | | align="center" style="background:#F5F5F5;" | | ||
* slow rate of transfusion | * slow rate of transfusion | ||
* avoid unnecessary transfusion | * avoid unnecessary transfusion | ||
* cardiac evluation | * cardiac evluation | ||
| +++ | | align="center" style="background:#F5F5F5;" |+++ | ||
|} | |} | ||
Revision as of 14:28, 16 October 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Khuram Nouman, M.D. [2] Amandeep Singh M.D.[2]
Overview
Types of Transfusion Reactions
Febrile Non-hemolytic Transfusion Reaction
- This is the most common adverse reaction to a blood transfusion.
- Symptoms include fever and dyspnea 1 to 6 hours after receiving the transfusion.
- Such reactions are clinically benign, causing no lasting side effects or problems, but are unpleasant via a blood transfusion is estimated, as of 2006, at 1 per 2 million units transfused. Bacterial infection is a much more common problem.
Bacterial Infection
- Blood products can provide an excellent medium for bacterial growth, and can become contaminated after collection while they are being stored.
- The risk is highest with platelet transfusion, since platelets must be stored near room temperature and cannot be refrigerated.
- The risk of severe bacterial infection and sepsis is estimated (as of 2001) at about 1 in 50,000 platelet transfusions, and 1 in 500,000 red blood cell transfusions.
Acute Hemolytic Reaction
- This is a medical emergency resulting from rapid destruction (hemolysis) of the donor red blood cells by host antibodies.
- The most common cause is clerical error (i.e. the wrong unit of blood being given to the wrong patient).
- The symptoms are fever and chills, sometimes with back pain and pink or red urine (hemoglobinuria).
- The major complication is that hemoglobin released by the destruction of red blood cells can cause acute renal failure.
Anaphylactic Reaction
- An anaphylactic (or severe allergic) reaction can occur at a rate of 1 per 30,000-50,000 transfusions.
- These reactions are most common in people with selective IgA deficiency (although IgA deficiency is often asymptomatic, and people may not know they have it until an anaphylactic reaction occurs).
Transfusion-associated Acute Lung Injury (TRALI)
- TRALI is a syndrome of acute respiratory distress, often associated with fever, non-cardiogenic pulmonary edema, and hypotension.
- It may occur as often as 1 in 2000 transfusions.
- Symptoms can range from mild to life-threatening, but most patients recover fully within 96 hours, and the mortality rate from this condition is less than 10%.
Volume Overload
- Patients with impaired cardiac function (eg congestive heart failure) can become volume-overloaded as a result of blood transfusion, leading to edema, dyspnea (shortness of breath), and orthopnea (shortness of breath while lying flat). *This is sometimes called TACO, or Transfusion Associated Circulatory Overload.
Iron overload
- Each transfused unit of red blood cells contains approximately 250 mg of elemental iron.
- Since elimination pathways for iron are limited, a person receiving numerous red blood cell transfusions can develop iron overload, which can in turn damage the liver, heart, kidneys, and pancreas. The threshold at which iron overload becomes significant is somewhat unclear, but is likely around 12-20 units of red blood cells transfused.
Transfusion-associated Graft-vs-Host Disease (GvHD)
- GVHD refers to an immune attack by transfused cells against the recipient. This is a common complication of stem cell transplantation, but an exceedingly rare complication of blood transfusion. It occurs only in severely immunosuppressed patients, primarily those with congenital immune deficiencies or hematologic malignancies who are receiving intensive chemotherapy. When GVHD occurs in association with blood transfusion, it is almost uniformly fatal. Transfusion-associated GVHD can be prevented by irradiating the blood products prior to transfusion.
Transfusion-associated Microchimerism (TA-MC)
- Transfusion-associated microchimerism is the stable persistence of donor's genetically distinct cells (usually <5%) in a recipient's circulation following fresh blood transfusion, especially in the setting of trauma.
- As a result of the current advancement in polymerase chain reaction techniques, TA-MC has been demonstrated among patients with trauma following blood transfusion, pregnancy and organ or stem cell transplantation. Several studies have implicated other forms of microchimerism, including fetomaternal microchimerism, with acute and chronic illnesses such as congenital heart block in a patient with neonatal lupus erythematosus and systemic sclerosis.
Genetic factors such as the TNF (-308A) single nucleotide polymorphisms (SNP) have been implicated in the development of TA-MC. The risk of developing TA-MC is largely dependent on the clinical setting, i.e., it is rare in situations which do not involve massive trauma. Although leukoreduction removes > 99.9% of donor's white blood cells, it has not been proven to prevent the development of TA-MC.
Treatment of Transfusion Reactions
The most important step in treating a presumed transfusion reaction is to stop the transfusion immediately (saving the remaining blood and IV tubing for testing) and to provide supportive care to the patient. More specific treatments depend on the nature and presumed cause of the transfusion reaction. Most hospitals and medical centers have transfusion reaction protocols, which specify testing of the blood product and patient for hemolysis, bacterial contamination, etc.
The following table shows different types of transfusion reactions along with their treatment,
Transfusion Reaction | Time of onset | Fever | Rigors | Rash | Blood Pressure | Additional Features | Labs | Treatment | Prevention | Mechanism/
Examples |
---|---|---|---|---|---|---|---|---|---|---|
Anaphylactic Reaction |
|
- | - | - |
|
|
|
|
|
IgA deficiency |
Bacterial Infection |
|
++ | + | +/- |
|
|
|
|
|
+/- |
Acute Hemolytic Reaction |
|
+ | + | +/- |
|
|
|
|
|
ABO incompatibility |
Febrile Non-hemolytic Transfusion Reaction |
|
+, with chills | + | - |
|
|
|
|
|
Cytokine in storage |
Transfusion-related acute lung injury (TRALI) | within 6 hours | +/- | +/- | - |
|
|
|
|
|
Donor anti-leukocyte antibodies |
Transfusion-associated circulatory overload (TACO) | usually over hours | - | - | - |
|
|
|
|
|
+++ |
Transfusion-related acute lung injury (TRALI) can be differentiated from Transfusion associated circulatory overload (TACO) as followed,
Parameters | Transfusion-related acute lung injury (TRALI) | Transfusion-associated circulatory overload (TACO) |
---|---|---|
Fever | +/- | - |
Blood pressure | hypotension | hypertension |
Respiratory Distress | + | + |
JVP | non-distended | distended |
Respiratory auscultation | Rales | Rales + S3 heart sounds may be present |
CXR | bilateral pulmonary infiltrates | bilateral pulmonary infiltrates |
Fluid balance | neutral | positive |
Diuretics | responsive only when there is fluid overload | Improvement with diuretics |
Ejection fraction | normal | decrease |
BNP | <250 pg/mL | >1200 pg/mL |
PCWP | <18 mm Hg | >18 mm Hg |
WBC | unchanged | transient decrease |
See also
External links
- ICD-10 Chapter T: World Health Organisation classification - Complications following infusion, transfusion and therapeutic injection